跳转至内容
Merck
CN

SML3878

KMR-206

≥94% (HPLC)

别名:

6-(4-(2-fluoro-5-((4-oxo-7-(prop-1-yn-1-yl)-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)nicotinonitrile

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C29H23FN6O2
化学文摘社编号:
分子量:
506.53
NACRES:
NA.21
Assay:
≥94% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

O=C(C1=CC(CC2=NNC(C3=C2C=C(C=C3)C#CC)=O)=CC=C1F)N4CCN(CC4)C5=NC=C(C=C5)C#N

assay

≥94% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

Quality Level

Biochem/physiol Actions

Cell penetrant, potent, and selective inhibitor of PARP7 that inhibits auto-MARylation and induced IFN-β in mouse colon carcinoma.
KMR-206 is a cell penetrant, potent, and selective inhibitor of PARP7 that inhibits auto-MARylation and induced IFN-β in mouse colon carcinoma (CT-26) cells. Also increased PARP7 protein levels in CT-26 cells.

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Z G Jia et al.
Zhonghua zhong liu za zhi [Chinese journal of oncology], 9(2), 124-126 (1987-03-01)
CT guided percutaneous fine needle aspiration cytodiagnosis was performed on 30 patients with pancreatic and periampullary tumors in China-Japan Friendship Hospital from November 1984 to January 1986. In our series, 9 pancreatic head cancers, 4 pancreatic body and tail cancers

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持